Skip to content
Paragon Biosciences LLC
  • About Us
  • Our Approach
  • Portfolio
  • Leadership
  • Careers
  • Contact Us
  • News Room

evozyne

5 items

  • February 12, 2026

    Biotech Innovation Update

    Last year, Paragon Biosciences and [...]

  • January 12, 2023

    Evozyne Creates AI Model with NVIDIA for Novel Protein Design, Expected to Accelerate Drug Development

    – New AI model, co-developed by Evozyne [...]

  • January 11, 2023

    Veteran Technology Executive Mike Gamson Named Evozyne CEO

    – Gamson to set commercial direction, strengthen [...]

  • August 6, 2020

    Sterling Bay Signs Lease with Evozyne, LLC at Lincoln Park Life Science Building, 2430 N Halsted

    Sterling Bay Signs Lease with Evozyne, LLC [...]

  • July 23, 2020

    Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology

    Publication in peer-reviewed journal Science demonstrates the foundation [...]

© 2026 Paragon Biosciences LLC | Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500, Chicago, IL 60611 |

© 2026 Paragon Biosciences LLC | Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500, Chicago, IL 60611

© 2026 Paragon Biosciences LLC
Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500
Chicago, IL 60611

Page load link
Go to Top